Tarpeyo
Payments companies reported to CMS as associated with Tarpeyo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tarpeyo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tarpeyo
These are the largest totals companies reported as associated with Tarpeyo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gerald Appel | New York, NY | Nephrology (Internal Medicine) | $358,434.52 |
| Jorge Larranaga | Kissimmee, FL | Nephrology (Internal Medicine) | $321,425.31 |
| Sreedhar Mandayam | Houston, TX | Nephrology (Internal Medicine) | $194,087.09 |
| Prince Anand | Danville, PA | Nephrology (Internal Medicine) | $156,930.77 |
| Sayna Norouzi | Loma Linda, CA | Nephrology (Internal Medicine) | $140,830.85 |
| Luis Alvarez | Palo Alto, CA | Nephrology (Internal Medicine) | $117,836.60 |
| German Hernandez | El Paso, TX | Nephrology (Internal Medicine) | $102,414.28 |
| Anand Reddy | Odessa, TX | Nephrology (Internal Medicine) | $97,205.60 |
| Anis Rauf | Hinsdale, IL | Nephrology (Internal Medicine) | $95,382.48 |
| Chike Nzerue | Cookeville, TN | Nephrology (Internal Medicine) | $93,654.01 |
Prescribed Tarpeyo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.